Education
About Us
Working with TipRanks
Follow Us
Can-Fite BioPharma Ltd. (IL:CANF)
:CANF
Total Valuation
Can Fite Bio has a market cap or net worth of 50.61M. The enterprise value is 6.66M.
Market Cap50.61M
Enterprise Value6.66M
Share Statistics
Can Fite Bio has 3,893,155,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,893,155,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Can Fite Bio’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -114.17%.
Return on Equity (ROE)-1.45
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-114.17%
Return on Capital Employed (ROCE)-1.15
Revenue Per Employee84.25K
Profits Per Employee-985.00K
Employee Count8
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Can Fite Bio is -1.44. Can Fite Bio’s PEG ratio is 0.06.
PE Ratio-1.44
PS Ratio0.00
PB Ratio3.80
Price to Fair Value2.09
Price to FCF-0.86
Price to Operating Cash Flow-0.86
PEG Ratio0.06
Income Statement
In the last 12 months, Can Fite Bio had revenue of 674.00K and earned -7.88M in profits. Earnings per share was 0.00.
Revenue674.00K
Gross Profit674.00K
Operating Income-8.13M
Pretax Income-7.88M
Net Income-7.88M
EBITDA-8.12M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Can Fite Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-63.89%
50-Day Moving Average1.48
200-Day Moving Average2.10
Relative Strength Index (RSI)43.16
Average Volume (3m)8.11M
Important Dates
Can Fite Bio upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMay 22, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Can Fite Bio as a current ratio of 4.38, with Debt / Equity ratio of 3.07%
Current Ratio4.38
Quick Ratio4.38
Debt to Market Cap0.00
Net Debt to EBITDA0.58
Interest Coverage Ratio-580.71
Taxes
In the past 12 months, Can Fite Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Can Fite Bio EV to EBITDA ratio is -0.82, with an EV/FCF ratio of -0.87.
EV to Sales9.83
EV to EBITDA-0.82
EV to Free Cash Flow-0.87
EV to Operating Cash Flow-0.87
Balance Sheet
Can Fite Bio has 8.92M in cash and marketable securities with $40.00K in debt, giving a net cash position of -8.88M billion.
Cash & Marketable Securities8.92M
Total Debt$40.00K
Net Cash-8.88M
Net Cash Per Share>-0.01
Tangible Book Value Per Share<0.01
Margins
Gross margin is 100.00%, with operating margin of -1206.23%, and net profit margin of -1169.14%.
Gross Margin100.00%
Operating Margin-1206.23%
Pretax Margin-1169.14%
Net Profit Margin-1169.14%
EBITDA Margin-1205.19%
EBIT Margin-1206.23%
Analyst Forecast
The average price target for Can Fite Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―